Cargando…
Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis
The aim of this retrospective study was to assess the efficacy and safety of cetuximab therapy for patients with locally advanced (LA) and recurrent/metastatic (R/M) oral squamous cell carcinoma (OSCC), with a specific focus on distant metastases (DMs). Data from 21 patients with unresectable LA and...
Autores principales: | Naruse, Tomofumi, Yanamoto, Souichi, Matsushita, Yuki, Sakamoto, Yuki, Morishita, Kota, Ohba, Seigo, Shiraishi, Takeshi, Yamada, Shin-Ichi, Asahina, Izumi, Umeda, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950138/ https://www.ncbi.nlm.nih.gov/pubmed/27446558 http://dx.doi.org/10.3892/mco.2016.928 |
Ejemplares similares
-
Lower gingival squamous cell carcinoma with brain metastasis during long-term cetuximab treatment: A case report
por: Naruse, Tomofumi, et al.
Publicado: (2018) -
Immunohistochemical study of vascular endothelial growth factor-C/vascular endothelial growth factor receptor-3 expression in oral tongue squamous cell carcinoma: Correlation with the induction of lymphangiogenesis
por: NARUSE, TOMOFUMI, et al.
Publicado: (2015) -
Histopathological and immunohistochemical study in keratocystic odontogenic tumors: Predictive factors of recurrence
por: Naruse, Tomofumi, et al.
Publicado: (2017) -
Tooth extraction in a patient after autologous skeletal myoblast sheet transplantation for severe dilated cardiomyopathy
por: Okuyama, Kohei, et al.
Publicado: (2017) -
Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab-resistant oral squamous cell carcinoma
por: Tsuchihashi, Hiroki, et al.
Publicado: (2020)